A carregar...
Targeting HER (ERBB) Signaling in Head and Neck Cancer: An Essential Update
HNC (head and neck cancer) remains the 6(th) most common carcinoma worldwide. The suboptimal survival and toxicities observed with conventional approaches warrant exploration of novel therapeutic strategies such as targeted therapies. Although targeting EGFR (epidermal growth factor receptor) with c...
Na minha lista:
| Publicado no: | Mol Aspects Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8028037/ https://ncbi.nlm.nih.gov/pubmed/26163475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mam.2015.07.001 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|